|Bid||12.50 x 1200|
|Ask||35.78 x 900|
|Day's Range||30.70 - 31.39|
|52 Week Range||26.51 - 37.37|
|Beta (5Y Monthly)||1.33|
|PE Ratio (TTM)||18.28|
|Earnings Date||Jun 21, 2022 - Jun 27, 2022|
|Forward Dividend & Yield||1.04 (3.32%)|
|Ex-Dividend Date||Apr 21, 2022|
|1y Target Est||35.64|
Subscribe to Yahoo Finance Plus to view Fair Value for PDCO
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care and impressive overseas growth.
Catalent's (CTLT) latest launch is expected to provide a reliable, reproducible and scalable path to clinic to its customers.
Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.